Oesophageal disease in the elderly.
Pelemans
W
W
Vantrappen
G
G
D000367:Age Factors; D000368:Aged; D000464:Alginates / Q000627:therapeutic use; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D001626:Bethanechol Compounds / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D003680:Deglutition Disorders / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D004106:Dilatation; D004294:Domperidone / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000601:surgery / Q000628:therapy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use; D008875:Middle Aged; D012824:Silicic Acid / Q000627:therapeutic use; D017693:Sodium Bicarbonate
D000464:Alginates; D001626:Bethanechol Compounds; D001639:Bicarbonates; D004338:Drug Combinations; D006635:Histamine H2 Antagonists; D012824:Silicic Acid; D004294:Domperidone; D000536:Aluminum Hydroxide; C007829:alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination; D017693:Sodium Bicarbonate; D008787:Metoclopramide